Evidence map›Paper›PMID 33623080›Full record

ArticleScientific reports2021

A surfactant polymer wound dressing protects human keratinocytes from inducible necroptosis.

Puneet Khandelwal, Amitava Das, Chandan K Sen, Sangly P Srinivas, Sashwati Roy, Savita Khanna

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Apoptosis and Cell Clearance in Skin Wound Healing.Advances in experimental medicine and biology · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Puneet Khandelwal *Department of Surgery, Indiana Center for Regenerative Medicine and Engineering, Indiana University School of Medicine, 975 W Walnut St, Medical Research Library Building, Indianapolis, IN, 46202, USA.
Amitava Das *Department of Surgery, Indiana Center for Regenerative Medicine and Engineering, Indiana University School of Medicine, 975 W Walnut St, Medical Research Library Building, Indianapolis, IN, 46202, USA.
Chandan K SenDepartment of Surgery, Indiana Center for Regenerative Medicine and Engineering, Indiana University School of Medicine, 975 W Walnut St, Medical Research Library Building, Indianapolis, IN, 46202, USA.
Sangly P SrinivasSchool of Optometry, Indiana University, 800 East Atwater Avenue, Bloomington, IN, 47405, USA.
Sashwati RoyDepartment of Surgery, Indiana Center for Regenerative Medicine and Engineering, Indiana University School of Medicine, 975 W Walnut St, Medical Research Library Building, Indianapolis, IN, 46202, USA.
Savita KhannaDepartment of Surgery, Indiana Center for Regenerative Medicine and Engineering, Indiana University School of Medicine, 975 W Walnut St, Medical Research Library Building, Indianapolis, IN, 46202, USA. sjkhanna@iu.edu.
Indiana University – Purdue University Indianapolis · USIndiana University School of MedicineIndiana University Bloomington · US

Funding

Diabetic Foot Ulcer Clinical Research UnitU01DK119099 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Gayle M Gordillo, Sashwati Roy · 2018 to 2026
$5.4M
Wound Healing Endpoint and RecurrenceR01NR015676 · NINR · OHIO STATE UNIVERSITY · PI GORDILLO, GAYLE M, ROY, SASHWATI · 2015 to 2019
$2.6M
Mechanisms Underlying Impaired Diabetic Wound HealingR01DK114718 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI ROY, SASHWATI · 2018 to 2021
$1.6M
Novel Regulators of Wound AngiogenesisR01GM108014 · NIGMS · OHIO STATE UNIVERSITY · PI SEN, CHANDAN K · 2015 to 2018
$1.2M
NIDDK NIH HHS R01 DK114718NIDDK NIH HHS U01 DK119099NIGMS NIH HHS R01 GM108014NINR NIH HHS R01 NR015676
6 · The paper itself

Abstract

Chronic wounds show necroptosis from which keratinocytes must be protected to enable appropriate wound re-epithelialization and closure. Poloxamers, a class of synthetic triblock copolymers, are known to be effective against plasma membrane damage (PMD). The purpose of this study is to evaluate the efficacy of a specific poloxamer, surfactant polymer dressing (SPD), which is currently used clinically as wound care dressing, against PMD in keratinocytes. Triton X-100 (TX100) at sub-lytic concentrations caused PMD as demonstrated by the efflux of calcein and by the influx of propidium iodide and FM1-43. TX100, an inducer of necroptosis, led to mitochondrial fragmentation, depletion of nuclear HMGB1, and activation of signaling complex associated with necroptosis (i.e., activation of RIP3 and phosphorylation of MLKL). All responses following exposure of human keratinocytes to TX100 were attenuated by pre- or co-treatment with SPD (100 mg/ml). The activation and translocation of phospho-MLKL to the plasma membrane, taken together with depletion of nuclear HMGB1, characterized the observed cell death as necroptosis. Thus, our findings show that TX100-induced plasma membrane damage and death by necroptosis were both attenuated by SPD, allowing keratinocyte survival. The significance of such protective effects of SPD on keratinocytes in wound re-epithelialization and closure warrant further studies.

Indexed as

Bandages, HydrocolloidNecroptosisCell MembraneCells, CulturedHaCaT CellsHMGB1 ProteinHumansMitochondriaProtein KinasesReceptor-Interacting Protein Serine-Threonine KinasesSurface-Active AgentsWound HealingHMGB1 ProteinHMGB1 protein, humanMLKL protein, humanProtein KinasesReceptor-Interacting Protein Serine-Threonine KinasesRIPK3 protein, humanSurface-Active Agents

Identifiers

PMID33623080
PMCPMC7902632
OpenAlexW3130283356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.